News

Civil Rights Act aimed to prevent workplace discrimination. Trump says it promotes bias and will stop enforcing it.
President Trump has taken steps to nullify a key component to the Civil Rights Act as he works to remove diversity, equity ...
Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial. Previous data showed that in the phase 3 JAVELIN ...
Cystectomy often treats bladder cancer. But bladder removal surgery can help other bladder problems, too. After cystectomy, your urine may need a new route to exit your body (urinary diversion).
President Donald Trump on Wednesday moved to dislodge a cornerstone of modern civil rights law through a sweeping executive ...
Johnson & Johnson's confidence in its bladder cancer therapy TAR-200 – dented by a negative phase 3 readout last year – seems to be justified. New data from the SunRISe-1 study of TAR-200 in ...
Oral presentation provides update from QUILT-3.032 on durable complete responses to ANKTIVA ® plus BCG in BCG-unresponsive non-muscle invasive bladder cancer carcinoma in situ (NMIBC CIS ...
According to the American Cancer Society (ACS), bladder cancer is more common in men than in women. By the end of 2025, an estimated 84,870 new cases and 17,420 deaths are expected in the United ...
The main symptom of bladder cancer is blood in your urine. This is the same for both men and women. Bladder cancer symptoms to look out for: blood in the urine problems passing urine bone, lower back ...
The City of Rochester plans to honor its rich civil rights history and the legacy of leaders by designing a park. The ...
TAR-200 is a groundbreaking therapy for early-stage bladder cancer, designed to deliver a sustained local release of medication directly into the bladder—right where it is needed," said Biljana ...
3 "Patients with bladder cancer need more effective treatment options that are both tolerable and easily incorporated into everyday practice, especially for those with HR-NMIBC, a highly recurrent ...